Collegium Pharmaceutical, Inc. (COLL) revenue

Revenue · fiscal 2025
$780.57M

Collegium Pharmaceutical, Inc. (COLL) reported revenue of $780.57M in fiscal 2025 (the year ended December 31, 2025). That is 23.6% higher than the $631.45M of fiscal 2024. Figures as of 18 Nov 2026, 10:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$780.57M
Change on fiscal 2024
+23.6%
Growth, 5 years
+20.3% a year
Highest on record
$780.57Mfiscal 2025
Lowest on record
$1.71Mfiscal 2016
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Collegium Pharmaceutical, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 20.3% a year. Across the 10 fiscal years on record (2016–2025), the highest was $780.57M in fiscal 2025 and the lowest $1.71M in fiscal 2016.

History · 10 fiscal years

Revenue by fiscal year

Collegium Pharmaceutical, Inc. revenue, year by year

Collegium Pharmaceutical, Inc. (COLL) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$780.57M 23.6% up
2024$631.45M 11.4% up
2023$566.77M 22.2% up
2022$463.93M 67.6% up
2021$276.87M 10.7% down
2020$310.02M 4.5% up
2019$296.70M 5.8% up
2018$280.41M 884.7% up
2017$28.48M 1,564.3% up
2016$1.71M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on COLL

Collegium Pharmaceutical, Inc., figure by figure

Collegium Pharmaceutical, Inc. (COLL) overview: price, valuation and scorecard

Collegium Pharmaceutical, Inc. revenue: questions and answers

What is Collegium Pharmaceutical, Inc.'s revenue?

Collegium Pharmaceutical, Inc. (COLL) reported revenue of $780.57M in fiscal 2025 (the year ended December 31, 2025). That is 23.6% higher than the $631.45M of fiscal 2024.

What is the growth rate of Collegium Pharmaceutical, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 20.3% a year.

What are the highest and lowest revenue figures on record for Collegium Pharmaceutical, Inc.?

Across the 10 fiscal years on record (2016–2025), the highest was $780.57M in fiscal 2025 and the lowest $1.71M in fiscal 2016.

How is Collegium Pharmaceutical, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Collegium Pharmaceutical, Inc. it is on record here for 10 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Collegium Pharmaceutical, Inc. (COLL) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/COLL/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.